Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Pain, Postoperative 10 Colorectal Neoplasms 10 Neoplasms 8 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Hemorrhage 4 Head and Neck Neoplasms 4 Agnosia 4 Rectal Neoplasms 3 Neurotoxicity Syndromes 3 Nasopharyngeal Carcinoma 3 Myoma 3 Multiple Endocrine Neoplasia Type 1 3 Meningioma 3 Lymphoma, Non-Hodgkin 3 Leiomyoma 3 Glioblastoma 3 Delirium 3 Colonic Neoplasms 3 Chronic Pain 3 Warts 2 Uterine Cervical Neoplasms 2 Stomatitis 2 Skin Neoplasms 2

Interventions

Propranolol 9 Timolol 5 Prednisolone 5 Adrenergic beta-Antagonists 3 Steroids 2 Solutions 2 Saline Solution 2 Prednisone 2 Methylprednisolone 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Urine Specimen Collection 1 Tomography, Optical Coherence 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Observation 1 Nadolol 1 Mupirocin 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Everolimus 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemangioma × Sodium Chloride × Clear all

NCT01685398 2023-09-21

Topical Timolol for Superficial Infantile Hemangioma

Mahidol University

Phase 3 Completed

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡